HCPCS Level II
J1120
Injection, acetazolamide sodium, up to 500 mg
Codes near J1120
These sit next to J1120 in the CMS Level II file. All J codes
- J1097Phenylephrine 10.16 mg/ml and ketorolac 2.88 mg/ml ophthalmic irrigation solution, 1 ml
- J1098Articaine ophthalmic, 8% solution, 0.4 ml
- J1100Injection, dexamethasone sodium phosphate, 1 mg
- J1105Dexmedetomidine, oral, 1 mcg
- J1110Injection, dihydroergotamine mesylate, per 1 mg
- J1130Injection, diclofenac sodium, 0.5 mg
- J1160Injection, digoxin, up to 0.5 mg
- J1162Injection, digoxin immune fab (ovine), per vial
- J1163Injection, diltiazem hydrochloride, 0.5 mg
- J1164Injection, diltiazem hydrochloride in 0.72% sodium chloride, 0.5 mg
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 00143-9006-01 | Acetazolamide Sodium | Hikma Pharmaceuticals USA Inc. | 1 |
| 00143-9503-01 | Acetazolamide Sodium | Hikma Pharmaceuticals USA Inc. | 1 |
| 23155-0313-31 | Acetazolamide Sodium | Heritage Pharmaceuticals Inc. | 1 |
| 23155-0831-31 | Acetazolamide Sodium | Heritage Pharmaceuticals Inc. | 1 |
| 25021-0839-20 | Acetazolamide | Sagent Pharmaceuticals | 1 |
| 39822-0190-01 | Acetazolamide Sodium | XGen Pharmaceuticals DJB, Inc. | 1 |
| 67457-0853-50 | Acetazolamide Sodium | Mylan Institutional LLC | 1 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.